Comparison of the effect of intermittent administration and continuous infusion of famotidine on gastric pH in critically ill patients

Results of a prospective, randomized, crossover study

A. A. Baghaie, M. Mojtahedzadeh, R. L. Levine, R. E. Fromm, K. K. Guntupalli, A. R. Opekun

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Objectives: To compare the effects of intermittent intravenous administration and continuous intravenous infusion of famotidine on gastric pH in critically ill patients. Design: A prospective, randomized, crossover study of continuous infusion and bolus administration of famotidine in critically ill patients. Setting: A 14-bed medical intensive care unit (ICU) of a 500-bed county hospital. Patients: Medical ICU patients requiring stress ulcer prophylaxis. Interventions: Patients were randomized to receive an equivalent dose of famotidine by continuous infusion or intravenous bolus for 24 hrs, and then were crossed over to the other arm of the study. Measurements and Main Results: Critically ill patients who met the inclusion criteria were randomly assigned to receive famotidine 20 mg iv over 10 mins, every 12 hrs or a continuous infusion of 1.7 mg/hr for 24 hrs. After a 16-hr washout period, patients crossed over to the other arm of the study. Gastric pH was monitored continuously for 24 hrs. A total of 710 gastric pH measurements were obtained for each phase of the study. The mean area under the pH-time curve for a 24-hr period was higher for continuous infusion than bolus administration (p = .05). Continuous infusion of famotidine maintained a gastric pH of ≥4 over a longer time period than bolus administration (20.8 hrs vs. 12.6 hrs, respectively; p < .01). Onset of therapeutic gastric pH for continuous infusion was slightly delayed as compared with bolus administration. Conclusions: Continuous infusion of famotidine is more effective than an equivalent dose given by intermittent bolus in maintaining the appropriate gastric pH necessary for prevention of stress ulceration. Delayed onset of effect may warrant a priming dose when famotidine is given by continuous infusion.

Original languageEnglish
Pages (from-to)687-691
Number of pages5
JournalCritical Care Medicine
Volume23
Issue number4
StatePublished - Apr 25 1995

Fingerprint

Famotidine
Critical Illness
Cross-Over Studies
Stomach
Intravenous Infusions
Intensive Care Units
County Hospitals
Intravenous Administration
Ulcer

Keywords

  • clinical trials, randomized
  • critically ill
  • crossover studies
  • famotidine
  • gastric mucosa
  • histamine (H)-receptor antagonist
  • infusion, intravenous, continuous
  • pH, gastric
  • stomach
  • stress
  • stress ulceration

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Comparison of the effect of intermittent administration and continuous infusion of famotidine on gastric pH in critically ill patients : Results of a prospective, randomized, crossover study. / Baghaie, A. A.; Mojtahedzadeh, M.; Levine, R. L.; Fromm, R. E.; Guntupalli, K. K.; Opekun, A. R.

In: Critical Care Medicine, Vol. 23, No. 4, 25.04.1995, p. 687-691.

Research output: Contribution to journalArticle

Baghaie, A. A. ; Mojtahedzadeh, M. ; Levine, R. L. ; Fromm, R. E. ; Guntupalli, K. K. ; Opekun, A. R. / Comparison of the effect of intermittent administration and continuous infusion of famotidine on gastric pH in critically ill patients : Results of a prospective, randomized, crossover study. In: Critical Care Medicine. 1995 ; Vol. 23, No. 4. pp. 687-691.
@article{82f49862df0c4dd2bd1f6aae5a0b4b65,
title = "Comparison of the effect of intermittent administration and continuous infusion of famotidine on gastric pH in critically ill patients: Results of a prospective, randomized, crossover study",
abstract = "Objectives: To compare the effects of intermittent intravenous administration and continuous intravenous infusion of famotidine on gastric pH in critically ill patients. Design: A prospective, randomized, crossover study of continuous infusion and bolus administration of famotidine in critically ill patients. Setting: A 14-bed medical intensive care unit (ICU) of a 500-bed county hospital. Patients: Medical ICU patients requiring stress ulcer prophylaxis. Interventions: Patients were randomized to receive an equivalent dose of famotidine by continuous infusion or intravenous bolus for 24 hrs, and then were crossed over to the other arm of the study. Measurements and Main Results: Critically ill patients who met the inclusion criteria were randomly assigned to receive famotidine 20 mg iv over 10 mins, every 12 hrs or a continuous infusion of 1.7 mg/hr for 24 hrs. After a 16-hr washout period, patients crossed over to the other arm of the study. Gastric pH was monitored continuously for 24 hrs. A total of 710 gastric pH measurements were obtained for each phase of the study. The mean area under the pH-time curve for a 24-hr period was higher for continuous infusion than bolus administration (p = .05). Continuous infusion of famotidine maintained a gastric pH of ≥4 over a longer time period than bolus administration (20.8 hrs vs. 12.6 hrs, respectively; p < .01). Onset of therapeutic gastric pH for continuous infusion was slightly delayed as compared with bolus administration. Conclusions: Continuous infusion of famotidine is more effective than an equivalent dose given by intermittent bolus in maintaining the appropriate gastric pH necessary for prevention of stress ulceration. Delayed onset of effect may warrant a priming dose when famotidine is given by continuous infusion.",
keywords = "clinical trials, randomized, critically ill, crossover studies, famotidine, gastric mucosa, histamine (H)-receptor antagonist, infusion, intravenous, continuous, pH, gastric, stomach, stress, stress ulceration",
author = "Baghaie, {A. A.} and M. Mojtahedzadeh and Levine, {R. L.} and Fromm, {R. E.} and Guntupalli, {K. K.} and Opekun, {A. R.}",
year = "1995",
month = "4",
day = "25",
language = "English",
volume = "23",
pages = "687--691",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Comparison of the effect of intermittent administration and continuous infusion of famotidine on gastric pH in critically ill patients

T2 - Results of a prospective, randomized, crossover study

AU - Baghaie, A. A.

AU - Mojtahedzadeh, M.

AU - Levine, R. L.

AU - Fromm, R. E.

AU - Guntupalli, K. K.

AU - Opekun, A. R.

PY - 1995/4/25

Y1 - 1995/4/25

N2 - Objectives: To compare the effects of intermittent intravenous administration and continuous intravenous infusion of famotidine on gastric pH in critically ill patients. Design: A prospective, randomized, crossover study of continuous infusion and bolus administration of famotidine in critically ill patients. Setting: A 14-bed medical intensive care unit (ICU) of a 500-bed county hospital. Patients: Medical ICU patients requiring stress ulcer prophylaxis. Interventions: Patients were randomized to receive an equivalent dose of famotidine by continuous infusion or intravenous bolus for 24 hrs, and then were crossed over to the other arm of the study. Measurements and Main Results: Critically ill patients who met the inclusion criteria were randomly assigned to receive famotidine 20 mg iv over 10 mins, every 12 hrs or a continuous infusion of 1.7 mg/hr for 24 hrs. After a 16-hr washout period, patients crossed over to the other arm of the study. Gastric pH was monitored continuously for 24 hrs. A total of 710 gastric pH measurements were obtained for each phase of the study. The mean area under the pH-time curve for a 24-hr period was higher for continuous infusion than bolus administration (p = .05). Continuous infusion of famotidine maintained a gastric pH of ≥4 over a longer time period than bolus administration (20.8 hrs vs. 12.6 hrs, respectively; p < .01). Onset of therapeutic gastric pH for continuous infusion was slightly delayed as compared with bolus administration. Conclusions: Continuous infusion of famotidine is more effective than an equivalent dose given by intermittent bolus in maintaining the appropriate gastric pH necessary for prevention of stress ulceration. Delayed onset of effect may warrant a priming dose when famotidine is given by continuous infusion.

AB - Objectives: To compare the effects of intermittent intravenous administration and continuous intravenous infusion of famotidine on gastric pH in critically ill patients. Design: A prospective, randomized, crossover study of continuous infusion and bolus administration of famotidine in critically ill patients. Setting: A 14-bed medical intensive care unit (ICU) of a 500-bed county hospital. Patients: Medical ICU patients requiring stress ulcer prophylaxis. Interventions: Patients were randomized to receive an equivalent dose of famotidine by continuous infusion or intravenous bolus for 24 hrs, and then were crossed over to the other arm of the study. Measurements and Main Results: Critically ill patients who met the inclusion criteria were randomly assigned to receive famotidine 20 mg iv over 10 mins, every 12 hrs or a continuous infusion of 1.7 mg/hr for 24 hrs. After a 16-hr washout period, patients crossed over to the other arm of the study. Gastric pH was monitored continuously for 24 hrs. A total of 710 gastric pH measurements were obtained for each phase of the study. The mean area under the pH-time curve for a 24-hr period was higher for continuous infusion than bolus administration (p = .05). Continuous infusion of famotidine maintained a gastric pH of ≥4 over a longer time period than bolus administration (20.8 hrs vs. 12.6 hrs, respectively; p < .01). Onset of therapeutic gastric pH for continuous infusion was slightly delayed as compared with bolus administration. Conclusions: Continuous infusion of famotidine is more effective than an equivalent dose given by intermittent bolus in maintaining the appropriate gastric pH necessary for prevention of stress ulceration. Delayed onset of effect may warrant a priming dose when famotidine is given by continuous infusion.

KW - clinical trials, randomized

KW - critically ill

KW - crossover studies

KW - famotidine

KW - gastric mucosa

KW - histamine (H)-receptor antagonist

KW - infusion, intravenous, continuous

KW - pH, gastric

KW - stomach

KW - stress

KW - stress ulceration

UR - http://www.scopus.com/inward/record.url?scp=0028932465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028932465&partnerID=8YFLogxK

M3 - Article

VL - 23

SP - 687

EP - 691

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 4

ER -